Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle

Journal of Applied Physiology

Volumn 99, Issue 6, 2005, Pages 2075-2079

  Keller, Charlotte ^a,b   Steensberg, Adam ^a   Hansen, Anne K ^a   Fischer, Christian P ^a   Plomgaard, Peter ^a   Pedersen, Bente Klarlund ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Interleukin 6 receptor

Indexed keywords

CYTOKINE RECEPTOR; GLYCOGEN; INTERLEUKIN 6 RECEPTOR; MESSENGER RNA; RNA 18S;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERGOMETER; EXERCISE; EXERCISE TEST; GENE EXPRESSION; GLYCOGEN METABOLISM; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; MALE; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RNA SEQUENCE; SKELETAL MUSCLE; TRAINING;

ADAPTATION, PHYSIOLOGICAL; ADULT; EXERCISE; EXERTION; GENE EXPRESSION REGULATION; GLYCOGEN; HUMANS; MALE; MUSCLE, SKELETAL; PHYSICAL FITNESS; RECEPTORS, INTERLEUKIN-6;

EID: 28044442051     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00590.2005     Document Type: Article

References (33)

1. Bauer J, Lengyel G, Bauer TM, Acs G, and Gerok W. Regulation of interleukin-6 receptor expression in human monocytes and hepatocytes. FEBS Lett 249: 27-30, 1989.
2. Carey AL, Rogers S, Pedersen BK, Steinberg GR, Macaulay SL, Kemp BE, and Febbraio M. Interleukin-6 augments insulin-stimulated phosphorylation of Akt and p39MAPK and increases insulin sensitivity both in vitro and in human in vivo. Keystone Symposia 2005, Keystone, CO: Diabetes Mellitus meeting, 2005, p. 41
3. Carmeliet P, Vankelecom H, Van Damme J, Billiau A, and Denef C. Release of interleukin-6 from anterior pituitary cell aggregates: developmental pattern and modulation by glucocorticoids and forskolin. Neuroendocrinology 53: 29-34, 1991.
4. MacDonald C, Wojtaszewski JF, Pedersen BK, Kiens B, and Richter EA. Interleukin-6 release from human skeletal muscle during exercise: relation to AMPK activity. J Appl Physiol 95: 2273-2277, 2003.
5. Febbraio MA and Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16: 1335-1347, 2002.
6. Febbraio MA, Hiscock N, Sacchetti M, Fischer CP, and Pedersen BK. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 53: 1643-1648, 2004.
7. Febbraio MA, Steensberg A, Keller C, Starkie RL, Nielsen HB, Krustrup P, Ott P, Secher NH, and Pedersen BK. Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans. J Physiol 549: 607-612, 2003.
8. Fischer CP, Plomgaard P, Hansen AK, Pilegaard H, Saltin B, and Pedersen BK. Endurance training reduces the contraction-induced interleukin-6 mRNA expression in human skeletal muscle. Am J Physiol Endocrinol Metab 287: E1189-E1194, 2004.
9. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, and Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25: 386-401, 2001.
10. Hansen AK, Fischer CP, Plomgaard P, Andersen JL, Saltin B, and Pedersen BK. Skeletal muscle adaptation: training twice every second day vs. training once daily. J Appl Physiol 98: 93-99, 2005.
11. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, and Graeve L. Interleukin-6-type cytokine signalling through the gp 130/Jak/STAT pathway. Biochem J 334: 297-314, 1998.
12. Holmes AG, Watt MJ, Carey AL, and Febbraio MA. Ionomycin, but not physiologic doses of epinephrine, stimulates skeletal muscle interleukin-6 mRNA expression and protein release. Metabolism 53: 1492-1495, 2004.
13. Hurley BF, Nemeth PM, Martin WH III, Hagberg JM, Dalsky GP, and Holloszy JO. Muscle triglyceride utilization during exercise: effect of training. J Appl Physiol 60: 562-567, 1986.
14. Keller C, Steensberg A, Pilegaard H, Osada T, Saltin B, Pedersen BK, and Neufer PD. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J 15: 2748-2750, 2001.
15. Keller C, Keller P, Marshal S, and Pedersen BK. IL-6 gene expression in human adipose tissue in response to exercise: effect of carbohydrate ingestion. J Physiol 550: 927-931, 2003.
16. Keller P, Penkowa M, Keller C, Steensberg A, Fischer CP, Giralt M, Hidalgo J, and Klarlund Pedersen B. Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6. FASEB J 19: 1181-1183, 2005.
17. Kelly M, Keller C, Avilucea PR, Keller P, Luo Z, Xiang X, Giralt M, Hidalgo J, Saha AK, Pedersen BK, and Ruderman NB. AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochem Biophys Res Commun 320: 449-454, 2004.
18. Nielsen HB, Secher N, and Pedersen BK. Lymphocytes and NK cell activity during repeated bouts of maximal exercise. Am J Physiol Regul Integr Comp Physiol 271: R222-R227, 1996.
19. Nielsen HB, Secher NH, Kappel M, Hanel B, and Pedersen BK. Lymphocyte, NK, and LAK cell responses to maximal exercise. Int J Sports Med 60-65, 1996.
20. Nieman DC, Davis JM, Henson DA, Walberg-Rankin J, Shute M, Dumke CL, Utter AC, Vinci DM, Carson JA, Brown A, Lee WJ, McAnulty SR, and McAnulty LS. Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run. J Appl Physiol 94: 1917-1925, 2003.
21. Nieman DC, Nehlsen-Canarella SL, Fagoaga OM, Henson DA, Utter A, Davis JM, Williams F, and Butterworth DE. Influence of mode and carbohydrate on the cytokine response to heavy exertion. Med Sci Sports Exerc 30: 671-678, 1998.
22. Ostrowski K, Rohde T, Zacho M, Asp S, and Pedersen BK. Evidence that IL-6 is produced in skeletal muscle during prolonged running. J Physiol 508: 949-953, 1998.
23. Paonessa G, Graziani R, De Serio A, Savino R, Ciapponi L, Lahm A, Salvati AL, Toniatti C, and Ciliberto G. Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling. EMBO J 14: 1942-1951, 1995.
24. Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, Wilder R, Gold PW, Deuster PA, and Chrousos GP. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol Endocrinol Metab 271: E601-E605, 1996.
25. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374: 1-20, 2003.
26. Peters M, Muller AM, and Rose-John S. Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. Blood 92: 3495-3504, 1998.
27. Ray A, LaForge KS, and Sehgal PB. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol Cell Biol 10: 5736-5746, 1990.
28. Rose-John S, Schooltink H, Lenz D, Hipp E, Dufhues G, Schmitz H, Schiel X, Hirano T, Kishimoto T, and Heinrich PC. Studies on the structure and regulation of the human hepatic interleukin-6 receptor. Eur J Biochem 190: 79-83, 1989.
29. Ruderman NB, Park H, Kaushik VK, Dean D, Constant S, Prentki M, and Saha AK. AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise. Acta Physiol Scand 178: 435-442, 2003.
30. Saito M, Yoshida K, Hibi M, Taga T, and Kishimoto T. Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. J Immunol 148: 4066-4071, 1992.
31. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, and Pedersen BK. Production of IL-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma IL-6. J Physiol 529: 237-242, 2000.
32. Van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Moller K, Saltin B, Febbraio MA, and Pedersen BK. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88: 3005-3010, 2003.
33. Winder WW. Malonyl-CoA - regulator of fatty acid oxidation in muscle during exercise. Exerc Sport Sci Rev 26: 117-132, 1998.